Bringing the fundamentals into focus…
Back to Arvinas, Inc.
How Arvinas, Inc. stacks up
ARVN · against 438 other Healthcare companies of similar size
Valuation
52/ 100
Above the middle of the pack.
Ranked #194 of 439 · scores higher than 55% of peers
Bars: peers in each 10-point band of the valuation score36 peers with a valuation score of 50–59, including ARVN · Click a bar to see the companies
Why valuation scores 52?
Weighted metrics compared with all Healthcare companies.A mix: stronger earnings yield, but weaker free cash flow yield than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -45.0% vs peer median 0.0%
- higher earnings for the price paid: stronger than 68% of peers. Earnings yield: 2.0% vs peer median 1.5%
- Cash exceeds market value plus debt, so EBITDA yield is not meaningful and is left out.
Metric by metric
Position: dot = ARVN, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ARVN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 425 reported | 3.7% | 0.4% | 71% | 30% | |
| EBITDA yieldHigher is better · 444 reported | 14.4% | 3.3% | 87% | 50% | |
| Free cash flow yieldHigher is better · 202 reported | -45.6% | -7.5% | 5% | 20% | |
| Book yieldHigher is better · 435 reported | 121.4% | 49.0% | 89% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around ARVN| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 1 | 2.9B HKD (≈$365M) | 99 | 84 | |
| 1 | 89.9B JPY (≈$611M) | 99 | 68 | |
| 1 | 3.1B HKD (≈$396M) | 99 | 61 | |
| 1 | 6.50T IDR (≈$403M) | 99 | 69 | |
| 185 | 474M USD | 54 | 46 | |
| 192 | 3.8B CNY (≈$531M) | 53 | 44 | |
| 192 | 759M USD | 53 | 54 | |
| 194 | 4.2B CNY (≈$590M) | 52 | 33 | |
| 194 | 457M USD | 52 | 58 | |
| 194 | 460M SGD (≈$350M) | 52 | 46 | |
| 194 | 374M USD | 52 | 66 | |
| 198 | 6.8B HKD (≈$867M) | 51 | 56 | |
| 198 | 26.5B INR (≈$317M) | 51 | 34 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score